SG151288A1 - 3-cyano-quinoline derivatives with antiproliferative activity - Google Patents
3-cyano-quinoline derivatives with antiproliferative activityInfo
- Publication number
- SG151288A1 SG151288A1 SG200901893-8A SG2009018938A SG151288A1 SG 151288 A1 SG151288 A1 SG 151288A1 SG 2009018938 A SG2009018938 A SG 2009018938A SG 151288 A1 SG151288 A1 SG 151288A1
- Authority
- SG
- Singapore
- Prior art keywords
- cyano
- antiproliferative activity
- quinoline derivatives
- compounds
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EPPCT/EP03/51059 | 2003-12-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG151288A1 true SG151288A1 (en) | 2009-04-30 |
Family
ID=34684508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG200901893-8A SG151288A1 (en) | 2003-12-18 | 2004-12-15 | 3-cyano-quinoline derivatives with antiproliferative activity |
Country Status (23)
Country | Link |
---|---|
US (4) | US7655642B2 (es) |
EP (1) | EP1696914B1 (es) |
JP (1) | JP4892353B2 (es) |
KR (1) | KR101158440B1 (es) |
CN (1) | CN1893944B (es) |
AR (1) | AR047060A1 (es) |
AT (1) | ATE446750T1 (es) |
AU (1) | AU2004298784B2 (es) |
BR (1) | BRPI0417609B8 (es) |
CA (1) | CA2549728C (es) |
DE (1) | DE602004023876D1 (es) |
EA (1) | EA200601176A1 (es) |
ES (1) | ES2335216T3 (es) |
HK (1) | HK1095742A1 (es) |
IL (1) | IL176358A (es) |
MX (1) | MXPA06007018A (es) |
NO (1) | NO337622B1 (es) |
NZ (1) | NZ547795A (es) |
SG (1) | SG151288A1 (es) |
TW (2) | TWI374879B (es) |
UA (1) | UA83880C2 (es) |
WO (1) | WO2005058318A1 (es) |
ZA (1) | ZA200604971B (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ547794A (en) | 2003-12-18 | 2009-11-27 | Janssen Pharmaceutica Nv | Pyrido- and pyrimidopyrimidine derivatives as anti-proliferative agents |
WO2005058318A1 (en) | 2003-12-18 | 2005-06-30 | Janssen Pharmaceutica N.V. | 3-cyano-quinoline derivatives with antiproliferative activity |
MY169441A (en) | 2004-12-08 | 2019-04-11 | Janssen Pharmaceutica Nv | 2,4, (4,6) pyrimidine derivatives |
NI200700147A (es) | 2004-12-08 | 2019-05-10 | Janssen Pharmaceutica Nv | Derivados de quinazolina inhibidores de cinasas dirigidos a multip |
JO3088B1 (ar) * | 2004-12-08 | 2017-03-15 | Janssen Pharmaceutica Nv | مشتقات كوينازولين كبيرة الحلقات و استعمالها بصفتها موانع كينيز متعددة الاهداف |
CN101365703B (zh) | 2005-11-16 | 2013-11-06 | S*Bio私人有限公司 | 杂烷基连接的嘧啶衍生物 |
US10517876B2 (en) | 2005-11-16 | 2019-12-31 | Cti Biopharma Corp. | Oxygen linked pyrimidine derivatives |
CA2654583C (en) | 2006-07-13 | 2015-11-24 | Janssen Pharmaceutica N.V. | Mtki quinazoline derivatives |
JPWO2008087736A1 (ja) * | 2007-01-19 | 2010-05-06 | 宇部興産株式会社 | アラルキルオキシ又はヘテロアラルキルオキシ基を有する芳香族アミンの製法 |
AU2008265104B2 (en) * | 2007-06-21 | 2013-09-12 | Janssen Pharmaceutica Nv | Indolin-2-ones and aza-indolin-2-ones |
AU2008281849B2 (en) | 2007-07-27 | 2013-11-28 | Janssen Pharmaceutica Nv | Pyrrolopyrimidines |
CN102127087B (zh) * | 2011-01-21 | 2012-07-04 | 江苏先声药物研究有限公司 | 喹唑啉衍生物 |
MA39823A (fr) | 2014-04-03 | 2018-01-09 | Janssen Pharmaceutica Nv | Dérivés de pyridine macrocyclique |
MA39822A (fr) | 2014-04-03 | 2018-02-06 | Janssen Pharmaceutica Nv | Dérivés de pyrimidine bicycle |
BR112018006873A2 (pt) | 2015-10-05 | 2018-11-06 | The Trustees Of Columbia University In The City Of New York | ativadores do fluxo autofágico e fosfolipase d e depuração de agregados de proteína incluindo tau e tratamento de proteinopatias |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5028613A (en) | 1990-02-16 | 1991-07-02 | Repligen Corporation | Novel pyrroloquinoline alkaloids and methods of use |
UA73073C2 (uk) | 1997-04-03 | 2005-06-15 | Уайт Холдінгз Корпорейшн | Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція |
US6002008A (en) | 1997-04-03 | 1999-12-14 | American Cyanamid Company | Substituted 3-cyano quinolines |
ATE255575T1 (de) | 1998-09-29 | 2003-12-15 | Wyeth Corp | Substituierte 3-cyanochinoline als protein tyrosine kinase inhibitoren |
US6288082B1 (en) | 1998-09-29 | 2001-09-11 | American Cyanamid Company | Substituted 3-cyanoquinolines |
KR101064530B1 (ko) | 2002-03-30 | 2011-09-14 | 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 | 티로신 키나아제 억제제로서의 4-(n-페닐아미노)-퀴나졸린/퀴놀린, 이를 함유하는 약제학적 조성물 및 이의 제조방법 |
PA8603801A1 (es) * | 2003-05-27 | 2004-12-16 | Janssen Pharmaceutica Nv | Derivados de la quinazolina |
WO2005058318A1 (en) * | 2003-12-18 | 2005-06-30 | Janssen Pharmaceutica N.V. | 3-cyano-quinoline derivatives with antiproliferative activity |
-
2004
- 2004-12-15 WO PCT/EP2004/053497 patent/WO2005058318A1/en active Application Filing
- 2004-12-15 EP EP04804849A patent/EP1696914B1/en active Active
- 2004-12-15 US US10/596,509 patent/US7655642B2/en active Active
- 2004-12-15 UA UAA200607006A patent/UA83880C2/ru unknown
- 2004-12-15 CN CN2004800375666A patent/CN1893944B/zh active Active
- 2004-12-15 ES ES04804849T patent/ES2335216T3/es active Active
- 2004-12-15 NZ NZ547795A patent/NZ547795A/xx unknown
- 2004-12-15 JP JP2006544439A patent/JP4892353B2/ja active Active
- 2004-12-15 DE DE602004023876T patent/DE602004023876D1/de active Active
- 2004-12-15 EA EA200601176A patent/EA200601176A1/ru unknown
- 2004-12-15 SG SG200901893-8A patent/SG151288A1/en unknown
- 2004-12-15 BR BRPI0417609A patent/BRPI0417609B8/pt active IP Right Grant
- 2004-12-15 MX MXPA06007018A patent/MXPA06007018A/es active IP Right Grant
- 2004-12-15 KR KR1020067014235A patent/KR101158440B1/ko active IP Right Grant
- 2004-12-15 AT AT04804849T patent/ATE446750T1/de not_active IP Right Cessation
- 2004-12-15 CA CA2549728A patent/CA2549728C/en active Active
- 2004-12-15 AU AU2004298784A patent/AU2004298784B2/en active Active
- 2004-12-17 TW TW093139380A patent/TWI374879B/zh active
- 2004-12-17 AR ARP040104751A patent/AR047060A1/es active IP Right Grant
- 2004-12-17 TW TW100107837A patent/TWI389890B/zh active
-
2006
- 2006-06-15 ZA ZA200604971A patent/ZA200604971B/xx unknown
- 2006-06-15 IL IL176358A patent/IL176358A/en active IP Right Grant
- 2006-07-18 NO NO20063324A patent/NO337622B1/no unknown
-
2007
- 2007-03-19 HK HK07102919.7A patent/HK1095742A1/xx unknown
-
2009
- 2009-11-24 US US12/624,708 patent/US8778920B2/en active Active
-
2013
- 2013-03-12 US US13/796,377 patent/US9040511B2/en active Active
-
2014
- 2014-05-23 US US14/285,760 patent/US9365517B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20063324L (no) | 3-cyano-kinolinderivater med antiproliferativ aktivitet | |
GB0124933D0 (en) | Chemical compounds | |
UA84010C2 (en) | Macrocyclic quinazoline derivatives as antiproliferative agents | |
DE60112974D1 (en) | Carbolinderivate | |
IL163781A0 (en) | Purine derivatives as kinase inhibitors | |
MY141196A (en) | Substituted pyrrolo-pyrazole derivatives as kinase inhibitors | |
SI1771178T1 (sl) | Uporaba K-252a in kinaznih inhibitorjev za preprečevanje ali zdravljenje patologij, povezanih s HMGB1 | |
UA93351C2 (uk) | Похідні фталазіну як інгібітори parp | |
WO2004037176A3 (en) | Quinazolinones and derivatives thereof as factor xa inhibitors | |
WO2004031401A3 (en) | Novel tyrosine kinases inhibitors | |
TW200642689A (en) | Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient | |
GEP20094785B (en) | Pyrrolopyrazoles, potent kinase inhibitors | |
WO2006061417A3 (en) | Macrocyclic quinazole derivatives and their use as mtki | |
BG108268A (en) | Pyrazolopyrimidines as therapeutic agents | |
MY132106A (en) | New pyridazin-3(2h)-one derivatives | |
WO2003048081A3 (en) | Glycinamides as factor xa inhibitors | |
DE60216233D1 (en) | Carbolinderivate | |
EP1675552A4 (en) | PREPARATION OF 1,6-DISUBSTITUTED AZABENIC ZIMIDAZOLES AS KINASE-INHIBITORS | |
HK1118534A1 (en) | Thieno-pyrimidine compounds having fungicidal activity | |
WO2007120333A3 (en) | Tetracyclic kinase inhibitors | |
MXPA05010521A (es) | Inhibidores de cinasa de amida de bifenilcarboxilica p38. | |
MXPA03002911A (es) | Compuestos quimicos. | |
WO2002070469A3 (en) | Selective pde3b inhibitors and use of the same in therapy | |
TW200628153A (en) | Novel compounds | |
GEP20105095B (en) | Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |